Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:57:29.218Z.
Calculation as of: 2026-10-06T16:57:29.218Z.
Quote observation: 2026-10-06T16:53:47.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5a8aae8e93f82a899e51ff603ce0499f2ee8a4244ac8b174beef8711f00adb15
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Spectral AI, Inc.
Market Cap
$54.10M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.61M
Operating Cash Flow Yield
47.22%
TTM Avg
50.32%
3Y Avg
31.17%
5Y Avg
36.60%
Market Cap
$51.91M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.33M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.38M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spectral AI, Inc. (MDAI) | $54.10M | N/A | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $53.63M | N/A | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $53.70M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $51.61M | 47.22% | 50.32% | 31.17% | 36.60% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $51.91M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | N/A | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.38M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $50.66M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $50.54M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
